This topic contains a solution. Click here to go to the answer

Author Question: A client is admitted with an exacerbation of chronic obstructive pulmonary disease (COPD). Which ... (Read 90 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
A client is admitted with an exacerbation of chronic obstructive pulmonary disease (COPD). Which medications would help with this client's symptoms?
 
  Standard Text: Select all that apply.
  1. Ipratropium (Atrovent)
  2. Tiotropium (Spiriva)
  3. Oxybutynin (Ditropan)
  4. Benztropine (Cogentin)
  5. Glycopyrrolate (Robinul)

Question 2

Which assessment findings does the nurse expect in a client who received a medication that is a muscarinic antagonist?
 
  Standard Text: Select all that apply.
  1. Dilated pupils
  2. Increased heart rate
  3. Hypoactive bowel sounds
  4. Deep rapid respirations
  5. Excessive salivation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Liamb2179

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

Correct Answer: 1,2
Rationale 1: The muscarinic antagonist ipratropium (Atrovent) is useful in treating chronic obstructive pulmonary disease because it will dilate the bronchi.
Rationale 2: The muscarinic antagonist tiotropium (Spiriva) is useful in treating chronic obstructive pulmonary disease because it will dilate the bronchi.
Rationale 3: The muscarinic antagonist oxybutynin (Ditropan) affects the smooth muscle of the bladder and detrusor muscle.
Rationale 4: The muscarinic antagonist benztropine (Cogentin) has mild effects on the central nervous system and helps treat mild symptoms of Parkinson disease.
Rationale 5: The muscarinic antagonist glycopyrrolate (Robinul) is used for peptic ulcer disease and to control excessive drooling.
Global Rationale: The muscarinic antagonist ipratropium (Atrovent) and tiotropium (Spiriva) are useful in treating chronic obstructive pulmonary disease because they will dilate the bronchi. The muscarinic antagonist oxybutynin (Ditropan) affects the smooth muscle of the bladder and detrusor muscle. The muscarinic antagonist benztropine (Cogentin) has mild effects on the central nervous system and helps treat mild symptoms of Parkinson disease. The muscarinic antagonist glycopyrrolate (Robinul) is used for peptic ulcer disease and to control excessive drooling.

Answer to Question 2

Correct Answer: 1,2,3,4
Rationale 1: Dilated pupils are an expected response from a muscarinic antagonist.
Rationale 2: Increased heart rate is an expected response from a muscarinic antagonist.
Rationale 3: Hypoactive bowel sounds are an expected response from a muscarinic antagonist.
Rationale 4: Deep rapid respirations are an expected response from a muscarinic antagonist.
Rationale 5: Excessive salivation is not an expected response from a muscarinic antagonist.
Global Rationale: Dilated pupils, increased heart rate, hypoactive bowel sounds, and deep respirations are all expected responses from a muscarinic antagonist. Excessive salivation is not an expected response from a muscarinic antagonist.





 

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library